APHA
Back to Annual Meeting
APHA 2007 APHA
Back to Annual Meeting
APHA Scientific Session and Event Listing
Session: Other Drugs: Treatment Issues
4176.0: Tuesday, November 06, 2007: 2:30 PM-3:30 PM
Poster
Other Drugs: Treatment Issues
Learning Objectives: Refer to the individual abstracts for learning objectives
Board 1    An evaluation of state priorities, guidelines and funding for infectious disease services in substance abuse treatment programs
Steven Kritz, MD, Lawrence S. Brown, MD, MPH, FASAM, R. Jeffrey Goldsmith, MD, Edmund J. Bini, MD, MPH, Jim Robinson, MEd, Don Alderson, MS, John Rotrosen, MD
Board 2Changes in hepatitis C virus (HCV) education and counseling delivery practices among drug treatment program staff participating in a targeted training
Corrine E. Munoz-Plaza, MPH, Shiela M. Strauss, PhD, Janetta Astone-Twerell, PhD, Don Des Jarlais, PhD, Marya Gwadz, PhD, Holly Hagan, PhD, Andrew Osborne, MS, Andrew Rosenblum, PhD
Board 3Evidence on multiple treatment services and reassessment of treatment plans
Frank S. Pearson, PhD, Michael L. Prendergast, PhD, Deborah Podus, PhD, Peter Vazan, PhD, Zachary Hamilton, MA, Lisa Greenwell, PhD
Board 4Modified Therapeutic Community (MTC) for co-occurring disorders: A synthesis of four studies
Stanley Sacks, PhD, Karen McKendrick, MPH
Board 5Physicians role in curbing the prescription drug abuse epidemic
Jessica Oswald
Board 6E-Therapy as an alternative to conventional substance abuse prevention and treatment
Erika Taylor, PhD, Erika Symonette, MS
Board 7Staffing Patterns in Methadone Treatment: An Examination of Differences Across Treatment Programs
Laura J. Dunlap, PhD, Gary A. Zarkin, PhD, Brendan Wedehase, BA
Board 8Substance Abuse Treatment Access: Relationship with Integration of EAP and Specialty Behavioral Health Benefits
Elizabeth L. Merrick, PhD, Constance M. Horgan, ScD, Dominic Hodgkin, PhD, Vanessa Azzone, PhD, Frank Holt, RN, BSN, Bernie McCann, MS, CEAP, Sharon Reif, PhD
Board 9Developing informational materials and training resources for physicians: Implications from NIDA's Primary Care Physician Outreach Project
Susan W. Hayashi, PhD
Board 10Ancillary and transitional assistance services at substance abuse treatment facilities: Effects of facility characteristics and implications to policy
Mesfin S. Mulatu, PhD, MPH, Jamie F. Chriqui, PhD, MHS, Duane C. McBride, PhD
See individual abstracts for presenting author's disclosure statement and author's information.
Organized by:Alcohol, Tobacco, and Other Drugs

The 135th APHA Annual Meeting & Exposition (November 3-7, 2007) of APHA